Dados B3 › OPTS3 × MLAS3
OPTS3 × MLAS3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | OPTS3 | MLAS3 | year |
|---|---|---|---|
| ROE | 0.0% | 0.0% | 2025 |
| ROIC | -0.5%! | 3.3% | 2025 |
| ROA | -1.3% | 2.3% | 2025 |
| Gross margin | 57.0% | 5.5% | 2023 |
| EBIT margin | 11.6% | -20.8% | 2023 |
| Net margin | — | 3.1% | no year where both have it |
| Net debt/EBITDA | — | -1.03x | no year where both have it |
| Current ratio | 0.02x | 1.92x | 2025 |
| Revenue growth (1y) | -47.2% | -20.2% | 2023 |
| Revenue growth (5y CAGR) | — | 6.6% | no year where both have it |
| Piotroski F-Score | 2/9! | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | OPTS3 | MLAS3 | year |
|---|---|---|---|
| P/E | — | — | None × 2025 |
| P/B | — | 0.37x | None × 2025 |
| EV/EBITDA | — | 5.71x | None × 2025 |
| FCF yield | — | 6.8% | None × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:14 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:14 UTC. If this does not match /saude, you are reading a cached copy.